Influence of vehicle composition variations on the in vitro and ex vivo clonazepam diffusion from hydrophilic ointment bases

Pharmaceutica Acta Helvetiae

Volumn 71, Issue 2, 1996, Pages 147-154

  Mura, Paola ^a   Nassini, Cinzia ^b   Proietti, Daniela ^b   Manderioli, Alfredo ^a   Corti, Piero ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Clonazepam; Ex vivo diffusion; Hydrophilic ointment; In vitro diffusion; Isopropylmyristate; Lauryl alcohol; Vaseline oil

Indexed keywords

CLONAZEPAM; LAURYL ALCOHOL; MACROGOL 400; MACROGOL 6000; MYRISTIC ACID ISOPROPYL ESTER; PETROLATUM;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DIFFUSION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; NONHUMAN; OINTMENT; RABBIT; SKIN PENETRATION; SPECTROPHOTOMETRY; VISCOSITY;

EID: 0030198460     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/0031-6865(96)00005-2     Document Type: Article

References (24)

1. Akhter, S.A. and Barry, B.W. (1984) Penetration enhancers in human skin. Effect of oleic acid and azone on flurbiprofen permeation. J. Pharm. Pharmacol. Suppl. 36, p. 7.
2. Barry, B.W. and Bennett, S.L. (1987) Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J. Pharm. Pharmacol. 39, 535-546.
3. Celesti, L., Murratzu, C., Valoti, M., Sgaragli, G. and Corti, P. (1992) The single-pass perfused rabbit ear as a model for studying percutaneous absorption of clonazepam. 1. General characteristics. Meth. Find. Exper. Clin. Pharmacol. 14, 701-709.
4. Celesti, L., Murratzu, C., Valoti, M., Sgaragli, P. and Corti, P., (1993) The single-pass perfused rabbit ear as a model for studying percutaneous absorption of clonazepam. II. Influence of hydrogel-borne propylene glycol and skin pretreatment with lauryl alcohol. Meth. Find. Exp. Clin. Pharmacol. 15, 49-56.
5. Clarke's (1986), Isolation and Identification of Drugs, A.C. Moffat (Ed), The Pharmaceutical Press, London, II Ed., p. 480.
6. Davis S.S, (1989), Symposium on topical administration of drugs, Vol. II, p. 94.
7. Doelker E., (1985) Cinétique et mécanismes de la libération controlée à partir des systèmes polymériques. In: Puisieux F., Doelker E. and Benoit J.P. (Eds.), Formes Pharmaceutiques Nouvelles, Tec and Doc (Lavoisier), Paris, pp. 74-75.
8. Hadgraft, J. and Ridout, G. (1987) Development of model membranes for percutaneous absorption measurements I: isopropylmiristate. Int. J. Pharm. 39, 149-153.
9. Leung, S.S, Robinson, J.R. and Lee, V.H. (1987) Parenteral products. In: Robinson, J.R. and Lee, V.H. (Eds), Controlled Drug Delivery, II Ed., Marcel Dekker, New York, pp. 452-454.
10. Loftsson, T., Gildersleeve, N., Soliman, R. and Bodor, N. (1989) Effect of oleic acid on diffusion of drugs through hairless mouse skin. Acta Pharm. Nord 1, 17-22.
11. Mollgaard, B. and Hollgaard, A. (1983) Permeation of estradiol through the skin - effect of vehicles. Int. J. Pharm. 15, 185-197.
12. Mura, P., Bettinetti, G.P., Liguori, A., Bramanti, G., Corti, P. and Murratzu, C. (1989) Formulation factors influencing the release of clonazepam from Carbopol hydrogels. Boll. Chim. Farm. 128, 326-331.
13. Mura, P., Liguori, A., Bramanti, G., Corti, P., Murratzu, C. and Celesti, L. (1990) In vitro study of clonazepam diffusion kinetics from solutions or hydrophilic gel. Pharm. Acta Helv. 11, 298-303.
14. Mura, P., Celesti, L., Valoti, M., Santoni, G. and Corti, P. (1994) The single-pass perfused rabbit ear as a model for studying percutaneous absorption of clonazepam. III. Influence of vehicle composition on drug permeation. Eur. J. Pharm. Biopharm. 40, 90-95.
15. Mura P., Nassini C., Proietti D., Manderioli A., Corti P. (1995). Effect of presence and type of lipophilic compound on the in vitro diffusion of clonazepam from hydrophilic ointment bases. Pharm. Acta Helv. 70, 175-180.
16. Poulsen, B.J. and Flynn, G.L. (1988) In vitro methods to study dermal delivery and percutaneous absorption. In: Bronaugh, R.L. and Maibach, H.I. (Eds.), Percutaneous Absorption, Dekker, New York, pp. 431-459.
17. Shah, V.P., Elkms, J., Lam, S.Y. and Skelly, J.P. (1989) Determination of in vitro drug release from hydrocortisone creams. Int. J. Pharm. 78, 53-59.
18. Sloan, K.B., Siver, K.G. and Koch, S.A.M. (1986) The effect of vehicle on the diffusion of salicyilic acid through hairless mouse skin. J. Pharm. Sci. 75, 744-749.
19. Smith, E.W. and Haigh, J.M. (1988) In vitro systems for the assessment of drug release from topical formulation and transmembrane permeation. In: Bronaugh, R.L. and Maibach, H.I. (Eds.), Percutaneous Absorption, Dekker, New York, pp. 465-508.
20. Touitou, E.T., Fabin, B., Dany, S. and Almog, S. (1988) Transdermal delivery of tetrahydrocannabinol, Int. J. Pharm. 43, 9-15.
21. Walters, K.A. (1989) Penetration enhancers and their use. In: Hadgraft, J. and Guy, R.H. (Eds), Transdermal Drug Delivery, Dekker, New York, pp. 197-233.
22. Yamada, M. and Uda, Y. (1987) Enhancement of percutaneous absorption of molsidomine. Chem. Pharm. Bull. 35, 3390-3398.
23. Zatz, J.L. and Sarpotdar, P.P. (1987) Influence of vehicles on skin penetration. In: Kidonieus, A.F. and Berner, B. (Eds), Transdermal Drug Delivery, Vol. II, CRC press, Boca Raton, Florida, pp. 86-98.
24. Ziegenmeyer, J. (1982) The influence of the vehicle on the absorption and permeation of drugs. In: Brandau, R. and Lippol, R.H. (Eds), Dermal and Transdermal Absorption, Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp. 73-89.